Carolina Talhari

Carolina Talhari

Auto-generated profile, based on publicly available information

Carolina Talhari

Programa de Pós-Graduação em Ciências Aplicadas à Dermatologia, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2022 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
RORosane Orofino-Costa
Rosane Orofino-Costa
DFDayvison Freitas
Dayvison Freitas
AEAndrea Reis Bernardes Engemann
Andrea Reis Bernardes Engemann
Anderson Messias RodriguesAnderson Messias Rodrigues
Anderson Messias Rodrigues
CTCarolina Talhari
Carolina Talhari
Priscila Marques de MacedoPriscila Marques de Macedo
Priscila Marques de Macedo
The increase in the zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis, which started in the late 1990s in Rio de Janeiro and is now found in almost all Brazilian states, has been equally advancing in neighboring countries of Brazil. Changes in the clinical-epidemiological profile, advances in the laboratory diagnosis of the disease, and therapeutic difficulties have been observed throughout these almost 25 years of the epidemic, although there is no national consensus. The last international guideline dates from 2007. Update the clinical classification, diagnostic methods and recommendations on the therapeutic management of patients with sporotrichosis. Twelve experts in human sporotrichosis were selected from different Brazilian regions, and divided into three work groups: clinical, diagnosis and treatment. The bibliographic research was carried out on the EBSCOHost platform. Meetings took place via electronic mail and remote/face-to-face and hybrid settings, resulting in a questionnaire which pointed out 13 divergences, resolved based on the opinion of the majority of the participants. The clinical classification and laboratory diagnosis were updated. Therapeutic recommendations were made for the different clinical forms. Publication of the first national recommendation, carried out by the Brazilian Society of Dermatology, aimed at the Brazilian scientific community, especially dermatologists, infectologists, pediatricians, family medicine personnel, and laboratory professionals who work in the management of human sporotrichosis.

23 May 2023 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
HMHelio Miot
Helio Miot
PCPaulo Criado
Paulo Criado
CCCaio César Silva de Castro
Caio César Silva de Castro
MIMayra Ianhez
Mayra Ianhez
CTCarolina Talhari
Carolina Talhari
PRPaulo Müller Ramos
Paulo Müller Ramos
The JAK-STAT signaling pathway mediates important cellular processes such as immune response, carcinogenesis, cell differentiation, division and death. Therefore, drugs that interfere with different JAK-STAT signaling patterns have potential indications for various medical conditions. The main dermatological targets of JAK-STAT pathway inhibitors are inflammatory or autoimmune diseases such as psoriasis, vitiligo, atopic dermatitis and alopecia areata; however, several dermatoses are under investigation to expand this list of indications. As JAK-STAT pathway inhibitors should gradually occupy a relevant space in dermatological prescriptions, this review presents the main available drugs, their immunological effects, and their pharmacological characteristics, related to clinical efficacy and safety, aiming to validate the best dermatological practice.

15 August 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
CTCarolina Talhari
Carolina Talhari
MMMarcelo Távora Mira
Marcelo Távora Mira
CMCesare Massone
Cesare Massone
ABAndréa Braga
Andréa Braga
ACAnette Chrusciak‐Talhari
Anette Chrusciak‐Talhari
STSinésio Talhari
Sinésio Talhari
Background. Although awareness of the relevance of leprosy and human immunodeficiency virus (HIV) coinfection is increasing worldwide, several aspects of this co-occurrence are not fully understood.

7 January 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ALAndré Luiz Leturiondo
André Luiz Leturiondo
ANAriani Batista Noronha
Ariani Batista Noronha
MNMonik Oney Oliveira Do Nascimento
Monik Oney Oliveira Do Nascimento
CFCynthia de Oliveira Ferreira
Cynthia de Oliveira Ferreira
FRFabíola da Costa Rodrigues
Fabíola da Costa Rodrigues
CTCarolina Talhari
Carolina Talhari
Early detection of leprosy and multidrug therapy are crucial to achieve zero transmission and zero grade II incapacities goals of World Health Organization. Leprosy is difficult to diagnose because clinical forms vary and there are no gold standard methods to guide clinicians. The serological rapid tests aid the clinical diagnosis and are available for field use. They are easy to perform, do not require special equipment or refrigeration and are cheaper than the molecular tests. We evaluated the performance of two rapid serological tests (PGL1 and NDO-LID) in the discrimination of leprosy cases from healthy individuals at the Alfredo da Matta Foundation, a reference center for the disease in Manaus, Amazonas, Brazil. PGL1 and NDO-LID rapid tests are capable of detecting specific antibodies of M. leprae, IgM and IgM/IgG, respectively. A total of 530 healthy subjects and 171 patients (50 with paucibacillary and 121 multibacillary leprosy) were included in the study. Among the paucibacillary leprosy patients, the sensitivity was 34.0 and 32.0% for the NDO-LID and PGL1, respectively. In multibacillary leprosy patients, the NDO-LID sensitivity was 73.6% and the PGL1 was 81.0%. Serological tests demonstrated specificities of 75.9% for PGL-1 and 81.7% for NDO-LID. The positive predictive value (PPV), negative predictive value (NPV) and accuracy in multibacillary patients were 47.9, 93.1, and 80.2% respectively for the NDO-LID, and 43.4, 94.6 76.8% for PGL1. The tests showed limited capacity in the diagnosis of the disease, however, the high negative predictive value of the tests indicates a greater chance of true negatives in this group favoring exclusion of leprosy. This characteristic of the ML flow test is important in aiding clinical Diagnosis, especially in a region endemic to the disease and with other confounding skin conditions.

1 January 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
ACAlberto Eduardo Cox Cardoso
Alberto Eduardo Cox Cardoso
ACAlberto Eduardo Oiticica Cardoso
Alberto Eduardo Oiticica Cardoso
CTCarolina Talhari
Carolina Talhari
MSMonica Santos
Monica Santos
These are cutaneous diseases caused by insects, worms, protozoa, or coelenterates which may or may not have a parasitic life. In this review the main ethological agents, clinical aspects, laboratory exams, and treatments of these dermatological diseases will be studied.

1 March 2021 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
VJVidal Haddad Junior
Vidal Haddad Junior
AMAdriana Lúcia Mendes
Adriana Lúcia Mendes
CTCarolina Chrusciak Talhari
Carolina Chrusciak Talhari
HMHelio Miot
Helio Miot
Urbanization, pollution and the modification of natural landscapes are characteristics of modern society, where the change in human relations with the environment and the impact on biodiversity are environmental determinants that affect the health-disease relationship. The skin is an organ that has a strong interface with the environment and, therefore, the prevalence patterns of dermatoses may reflect these environmental changes. In this article, aspects related to deforestation, fires, urbanization, large-scale agriculture, extensive livestock farming, pollution and climatic changes are discussed regarding their influence on the epidemiology of skin diseases. It is important that dermatologists be aware of their social responsibility in order to promote sustainable practices in their community, in addition to identifying the impacts of environmental imbalances on different dermatoses, which is essential for the prevention and treatment of these diseases.